Mark Hennon Selected Research

Mark Hennon Research Topics

8	Neoplasms (Cancer) 07/2021 - 03/2013
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2018 - 01/2017
3	Adenocarcinoma 01/2019 - 01/2018
2	Margins of Excision 01/2021 - 11/2018
2	Esophageal Neoplasms (Esophageal Cancer) 12/2019 - 01/2019
2	Lung Neoplasms (Lung Cancer) 01/2018 - 03/2013
2	Carcinoma (Carcinomatosis) 01/2017 - 03/2013
1	Pathologic Constriction (Stenosis) 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2019
1	Pneumonia (Pneumonitis) 01/2018
1	Hemorrhage 01/2017
1	Intraoperative Complications 11/2016
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Neoplasm Micrometastasis 03/2013

1	2',3'- didehydro- 2',3'- dideoxy- 5- chlorocytidineIBA 07/2021
1	thiamine triphosphorate (TTP)IBA 07/2021
1	ElementsIBA 11/2017
1	Iridium-192IBA 11/2016
1	Vascular Endothelial Growth FactorsIBA 03/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2013
1	Vascular Endothelial Growth Factor CIBA 03/2013
1	Vascular Endothelial Growth Factor DIBA 03/2013
1	Keratin-7 (Cytokeratin 7)IBA 03/2013
1	human FLT4 proteinIBA 03/2013
1	Messenger RNA (mRNA)IBA 03/2013
1	Cell Adhesion MoleculesIBA 03/2013
1	Carcinoembryonic AntigenIBA 03/2013
1	Proteins (Proteins, Gene)FDA Link 03/2013

4	Radiotherapy 07/2021 - 01/2017
4	Therapeutics 11/2018 - 01/2016
3	Esophagectomy 01/2020 - 01/2018
3	Neoadjuvant Therapy 01/2019 - 11/2017
2	Length of Stay 01/2021 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2019 - 11/2018
2	Lymph Node Excision (Lymph Node Dissection) 11/2018 - 11/2017
2	Segmental Mastectomy (Lumpectomy) 01/2018 - 01/2018
1	Thoracotomy 01/2021
1	Immunotherapy 01/2017
1	Pneumonectomy (Lung Volume Reduction) 01/2017
1	Brachytherapy 11/2016
1	Operative Time 11/2016